Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'

Schizophrenia Research

Volumn 71, Issue 2-3, 2004, Pages 227-237

  Mason, Oliver ^a   Startup, Mike ^b   Halpin, Sean ^c   Schall, Ulrich ^b   Conrad, Agatha ^d   Carr, Vaughan ^b,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Ctr Mental Hlth Studs Psychol A   (Australia)

^d NSW   (Australia)

^e NSW   (Australia)

Author keywords

At risk mental states; First episode psychosis; Risk factors

Indexed keywords

ADOLESCENT; ADULT; ANHEDONIA; ANTISOCIAL BEHAVIOR; ARTICLE; AUDITORY HALLUCINATION; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NEWBORN DISEASE; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SCHIZOTYPAL PERSONALITY DISORDER; SENSITIVITY AND SPECIFICITY; SOCIAL INTERACTION;

ADOLESCENT; ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 4944260378     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.04.006     Document Type: Article

References (49)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. ed.:1987;American Psychiatric Association, Washington, DC
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed.:1994;American Psychiatric Association, Washington, DC
3. Amundson M.E., Hart C.A., Holmes T.H. Manual for the Schedule of Recent Experience (SRE). 1981;University of Washington Press, Seattle, Washington
4. Andreasen N. The Scale For The Assessment Of Negative Symptoms (SANS). 1983;University of Iowa, Iowa City, IA
5. Andreasen N. The Scale For The Assessment Of Positive Symptoms (SAPS). 1984;University of Iowa, Iowa City, IA
6. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia: methods, meanings, and mechanisms. Arch. Gen. Psychiatry. 52:1995;341-351
7. Bebbington P., Wilkins S., Jones P.B., Foerster A. Life events and psychosis: initial results from the Camberwell Collaborative Psychosis Study. Br. J. Psychiatry. 162:1993;72-79
8. Bentall R.P., Morrison A.P. More harm than good: the case against using anti-psychotic drugs to prevent severe mental illness. J. Mental Health. 11:2002;351-356
9. Buhler B., Hambrecht M., Loffler W., an der Heiden W., Hafner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse: a retrospective and prospective study of 232 population-based first illness episodes. Schizophr. Res. 54:2002;243-251
10. Cannon-Spoor H.E., Potkin S.G., Wyatt K.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 8:1982;470-484
11. Carr V., Halpin S., Lau N., O'Brien S., Beckmann J., Lewin T. A risk factor screening and assessment protocol for schizophrenia and related psychosis. Aust. N. Z. J. Psychiatry. 34:2000;170-180
12. Cornblatt B., Lencz T., Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr. Res. 54:2002;177-186
13. David A.S., Malmberg A., Brandt L., Allebeck P., Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Br. J. Psychiatry. 27:1997;1311-1323
14. Davidson M., Reichenberg A., Rabinowitz J., Weiser M., Kaplan Z., Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am. J. Psychiatry. 156:1999;1328-1335
15. Degenhardt L. The link between cannabis use and psychosis: furthering the debate. Psychol. Med. 33:2003;3-6
16. DeGrazia D. Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia. Schizophr. Res. 51:2001;77-86
17. Done D.J., Crow T.J., Johnstone E.C., Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 309:1994;699-703
18. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of current and lifetime substance use in schizophrenia. Schizophr. Bull. 24:1998;443-455
19. Geddes J.R., Verdoux H., Takei N. Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr. Bull. 25:2001;413
20. Hamilton M. The assessment of anxiety states by rating. Br. J. Psychiatry. 32:1959;50-55
21. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-61
22. Hawkins N.G., Davies R., Holmes T.H. Evidence of psychosocial factors in the development of pulmonary tuberculosis. Am. Rev. Tuberc. Pulm. Dis. 75:1957;768-780
23. Heinrichs D.W., Hanlon T.E., Carpenter W.T. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10:1984;388-398
24. Jablensky A., McGrath J., Herrman H., Castle D., Gureje O., Evans M., Carr V., Morgan V., Korten A., Harvey C. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Aust. N. Z. J. Psychiatry. 34:2000;221-236
25. Jackson H.J., McGorry P.D., McKenzie D. The reliability of DSM-III prodromal symptoms in first-episode psychotic patients. Acta Psychiatr. Scand. 90:1994;375-378
26. Jackson H.J., McGorry P.D., Dakis J., Harrigan S., Henry L., Mihalopoulos C. The inter-rater and test-retest reliabilities of prodromal symptoms in first-episode psychosis. Aust. N. Z. J. Psychiatry. 30:1996;498-504
27. Jones P., Murray R., Jones P., Rodgers B., Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 344:1994;1398-1402
28. Kwapil T.R. Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. J. Abnorm. Psychol. 107:1998;558-565
29. Lewis S.W., Murray R.M. Obstetric complications, neuro-developmental deviance, and risk of schizophrenia. J. Psychiat. Res. 4:1987;413-421
30. Loranger A.W., Sartorius N., Andreoli A., Berger P., Buchheim P., Channabasavanna S.M., Coid B., Dahl A., Diekstra R.F.W., Ferguson B., Jacobsberg L.B., Mombour W., Pull C., Ono Y., Regier D.A. The international personality disorder examination. The World Health Organization/Alcohol, drug abuse, and mental health administration pilot study of personality disorders. Arch. Gen. Psychiatry. 51:1994;215-224
31. Lukoff D., Neuchterlein K., Ventura J. Manual for the expanded Brief Psychiatric Rating Scale. Schizophr. Bull. 12:1986;594-602
32. Malmberg A., Lewis G., David A., Allebeck P. Premorbid adjustment and personality in people with schizophrenia. Br. J. Psychiatry. 172:1998;308-313
33. Maxwell M.E. Manual for the FIGS. 1992;National Instititue of Mental Health, Bethesda, MD
34. McGlashan T.H., Miller T.J., Woods S.W. Pre-onset detection and intervention in schizophrenia psychoses: current estimates of benefits and risk. Schizophr. Bull. 27:2001;563-570
35. McGlashan T.H., Zipursky R.B., Perkins D., Addington J., Miller T.J., Woods S.W., Hawkins K.A., Hoffman R., Lindborg S., Tohen M., Breier A. The PRIME North America randomised double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rationale and design. Schizophr. Res. 61:2003;7-18
36. McGorry P., Elkins K., Curry C., Copolov D., Singh B. Royal Park Multidiagnostic Instrument for Psychosis. Version 2 (Revised). Part 1 Interview Schedule. 1989;National Health and Medical Research Council, Mellourne, Australia
37. McGorry P.D., McFarlane C., Patton G.C., Bell R., Hibbert M.E., Jackson H.J., Bowes G. The prevalence of prodromal features of schizophrenia in adolescence; a preliminary survey. Acta Psychiatr. Scand. 92:1995;241-249
38. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., Germano D., Bravin J., McDonald T., Blair A., Adlard S., Jackson H. Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry. 59:2002;921-928
39. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch. Gen. Psychiatry. 48:1991;764-770
40. Miller P., Byrne M., Hodges A., Lawrie S.M., Owens D.G.C., Johnstone E.C. Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-risk Study. Br. J. Psychiatry. 180:2002;179-184
41. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., Woods S.W. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry. 159:2002;863-865
42. Mrazek P.J., Haggerty R.J. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. 1994;National Academy Press, Washington, DC
43. Nelson H.E. National Adult Reading Test. 2nd. edn.:1991;NFER-Nelson, London
44. Schaffner K.F., McGorry P.D. Preventing severe mental illness: new prospects and ethical challenges. Schizophr. Res. 51:2001;3-15
45. Thurlow H.J. Illness in relation to life situation and sick-role tendency. J. Psychosom. Res. 15:1971;73-88
46. Yung A.R., McGorry P.D., McFarlane C.A., Jackson H.J., Patton C., Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 22:1996;283-303
47. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C., Francey S.M.A., Harrigan S., Patton G.C., Jackson H.J. Prediction of psychosis: a step towards indicated prevention of schizophrenia. Br. J. Psychiatry. 172(Suppl. 33):1998;14-20
48. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. Psychosis prediction: 12-month follow-up of a high-risk ("prodromal") group. Schizophr. Res. 60:2003;21-32
49. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 67:2004;131-142